[a]https%3A%2F%2Fwww.prometheusbio.com%2Fproducts%2Fcolloidal-gold-platform%2F[/a] <br>#Colloidal #Gold #Platform <br>A colloidal gold platform is a diagnostic technology that uses gold nanoparticles to detect the presence of biomolecules or microorganisms in a patient sample. The technology relies on the principles of immunochromatography, where the sample is added to a device containing gold labels coated with antibodies or antigens. If the target biomolecule or microorganism is present, it will bind to the gold label, resulting in a visible change, such as a color change. Colloidal gold platforms are commonly used in rapid diagnostic tests for infectious diseases, such as HIV, malaria, and COVID-19. The technology is affordable, easy to use, and produces results quickly, making it a valuable diagnostic tool in resource-limited settings. <br> <br>Types of Colloidal Gold Platform <br>DOA Reader <br>A DOA reader is a medical device used to diagnose dead or dying tissue in various organs of the body. It measures changes in oxygen levels in the affected tissue to determine its viability. <br> <br>How Does A Colloidal Gold Platform Work? <br>A colloidal gold platform works by using gold nanoparticles that are coated with antibodies or antigens to detect the presence of specific biomolecules or microorganisms in a patient sample. If the target molecule is present, it binds to the gold label, resulting in a visible change such as a color change. <br> <br>What Are The Advantages Of Using A Colloidal Gold Platform? <br>The advantages of using a colloidal gold platform include affordability, simplicity, and ease of use. The technology provides quick results, making it ideal for use in resource-limited settings. Colloidal gold platforms can also be used for a variety of diagnostic applications.

[a]https%3A%2F%2Fwww.prometheusbio.com%2Fproducts%2Fcardial-troponin-i-ctni-test-cassette%2F[/a] <br>#cTnI #Blood #Test <br>Cardial Troponin I (cTnI) Test Cassette <br>This kit is used for in vitro quantitative detection of the concentrations of Cardial Troponin I (cTnI) in human serum/plasma and whole blood samples. <br> <br>In clinical, Cardial Troponin I (cTnI) is used to detect the severity and prognosis of myocardial injury. And is an ideal biomarker for myocardial injury. <br> <br>Features of cTnI Blood Test Cassette <br> <br>Detecting the severity and prognosis of myocardial injury <br> <br>Identify the presence or absence of myocardial infarction <br> <br>Markers of myocardial injury and necrosis <br> <br>Indicating myocardial injury <br> <br>Significant value in the diagnosis of acute myocardial infarction <br> <br>High myocardial specificity and sensitivity for the diagnosis of acute coronary syndrome <br> <br>Product Details <br>Applicable Instrument: AFS-1000，AFS2000A <br>Format/Shape Cassette <br>Sample Whole blood, serum, or plasma <br>Test Range 0.2ng/mL～50 ng/mL <br>Time to Result 15 minutes <br>Clinical Significance myocardial infarct <br>Shelf Life/Validity 12 months <br>Storage Store in dark at 4 ℃ to 30 ℃. Use within 1 hour under conditions of humidity below 60%, and use immediately after opening the bag if the humidity exceeds 60%. <br>Packing 20 kits/box; 40 kits/box <br>Registration NMPA